Dynamic quotes: Off
|
Company Description (as filed with the SEC)
Our legal and commercial name is BioLineRx Ltd. We are a company limited by shares organized under the laws of the State of Israel. Our principal executive offices are located at 19 Hartum Street, Jerusalem 9777518, Israel, and our telephone number is +972 (2) 548-9100. We were founded in 2003 by leading institutions in the Israeli life sciences industry, including Teva Pharmaceutical Industries Ltd., or Teva. We completed our initial public offering in Israel in February 2007 and our ordinary shares are traded on the TASE under the symbol “BLRX.” In July 2011, we listed our ADSs on Nasdaq and they are traded under the symbol “BLRX.” Our capital expenditures for the years ended December 31, 2010, 2011 and 2012 were $0.5 million, $0.3 million and $0.2 million, respectively. Our current capital expenditures involve acquisitions of laboratory equipment, computers and communications equipment. B. ... More ...
Analyst Info |
|
| Annual EPS Est: | $-1.2 |
| Quarterly EPS Est: | -0.02 |
| PEG Ratio: | -.02 |
|
Mean Recommendation: View Summary / View All |
1 |
Data is provided by Zacks Investment Research

